USPTO USPTO Rules in Favor of Broad Institute in CRISPR/Cas9 IP Dispute The Broad's CRISPR/Cas9 patents were found to have priority over similar IP from the University of California and others. Taiwanese Firm's IP Asserted in Suit Against Pacific Biosciences Found Partially Unpatentable This week, the US PTAB found that some claims of a Personal Genomics patent for single-molecule detection didn't hold up, while others remain valid. US Appeals Court Upholds Invalidation of Columbia University Sequencing Chemistry Patents The appellate court's decision deals a blow to a 2017 Columbia University lawsuit that alleged Illumina infringed one of the invalidated patents. Rakuten Medical Sues Illumina Over Trademark Dispute The cancer therapy developer has asked a US federal court to declare that its Illuminox platform does not infringe Illumina's trademarks. USPTO Board Denies Illumina Request to Review BGI Patent Illumina had argued that Complete Genomics' patent covering two-color sequencing-by-synthesis chemistry was obvious, but the US PTAB disagreed. Aug 1, 2019 CRISPR Patent Fight Turns Ugly as UC Accuses Broad Researchers of Lying About Claims Jul 31, 2019 CRISPR Patent Pools Pop Up, But Participation Uncertain as IP Holders Continue Legal Battles Premium Jun 25, 2019 CRISPR Patent Fight Between UC Berkeley, Broad Flares Up as USPTO Initiates New Interference Jun 14, 2019 USPTO Denies Foundation Medicine Attempt to Invalidate Guardant Health Patent Jul 18, 2018 Inscripta Confirms CRISPR-MAD7 Editing Activity in Mammalian Cells, Releases New MAD2 Enzyme Premium Jan 17, 2018 Rockefeller, Broad Settle CRISPR IP Dispute; EPO Denies Broad European Patent Oct 28, 2016 CRISPR Patent Interference Likely Heads to Oral Arguments Over Preliminary Motions Premium Jun 1, 2016 Illumina Sues Qiagen for Patent Infringement Oct 9, 2015 USPTO Report to Congress Says No Immediate Action Necessary on Confirmatory Genetic Testing Nov 6, 2014 IP Update: Recent Patents Awarded to Alnylam Pharmaceuticals, Marina Biotech, and More Premium Oct 30, 2014 IP Update: Recent Patents Awarded to SomaGenics, Pioneer Hi-Bred, and More Premium Oct 29, 2014 USPTO Appeals Board Invalidates Claims on Illumina Patent Included in Qiagen-IBS Litigation Oct 16, 2014 IP Update: Recent Patents Awarded to Alnylam, Quark, Qiagen, and More Premium Sep 25, 2014 IP Update: Recent Patents Awarded to Alnylam, GE Healthcare, Sanofi, and More Premium Aug 27, 2014 Legal Experts Assess Potential Impact of GeneDx's IPR Challenge of Myriad Patents Premium Aug 19, 2014 GeneDx Files IPR Petitions at USPTO against 11 Patents at Issue in Myriad Lawsuit Aug 14, 2014 IP Update: Recent Patents Awarded to Alnylam, Tekmira, Polyplus, and More Premium Aug 7, 2014 IP Update: Recent Patents Awarded to Alnylam, RXi, IBM, and More Premium Jul 31, 2014 IP Update: Recent Patents Awarded to City of Hope, Alnylam, and More Premium Jul 3, 2014 IP Update: Recent Patents Awarded to Quark, Regulus, Alnylam, and More Premium Load More Breaking News Long COVID Clues Found in Acute SARS-CoV-2 Infection Blood Samples People in the News at Roche, Mammoth Biosciences, NeoGenomics, Molecular Assemblies, More New Products Posted to GenomeWeb: Thermo Fisher, Element Biosciences, Dante Genomics, More Tesis Biosciences to Develop miRNA Biomarkers for mTBI Diagnosis In Brief This Week: Danaher, Lucira Health, Novacyt, Molecular Devices The Scan Cell Atlas of Human Lung Development Gives View of Developing Airway Researchers have generated a cell atlas of human lung development, which they report in Cell. Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis. Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity. Study Links Genetic Risk for ADHD With Alzheimer's Disease A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.